In accordance with its long-term incentive program (“LTIP”) Ambu A/S has allocated performance share units (PSUs) to members of the Executive Board. Reference is made to the company announcement of 29 January 2021 regarding the implementation of the program and the first allocations.
Pursuant to the Market Abuse Regulation article 19, Ambu A/S hereby notifies receipt of information of the following transactions in Ambu’s shares by persons discharging managerial responsibilities in Ambu A/S.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||
| a) | Name | Michael Højgaard Abrahamsen | ||
| 2. | Reason for the notification | |||
| a) | Position/status | CFO | ||
| b) | Initial notifica- tion/Amendment | Initial notification | ||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc- tion monitor |
|||
| a) | Name | Ambu A/S | ||
| b) | LEI | 5299008W2A69WX355710 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
| a) | Description of the financial instrument, type of instru- ment
Identification code |
Performance Share Units linked to shares in Ambu A/S
DK0060946788 |
||
| b) | Nature of the transaction | Allocation of Performance Share Units according to Long-Term Incentive Program. | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| DKK 0 | 7,254 PSUs | |||
| d) | Aggregated information
|
N/A
N/A
|
||
| e) | Date of the transaction | 29 January 2021 | ||
| f) | Place of the transaction | Outside a trading venue | ||
Attachment
ST. PAUL, Minn., Dec. 16, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that it…
ValuePenguin finds in 45 states, 2026 Health Insurance Premiums are Increasing by More Than 10%…
In this free webinar, learn about the advantages of leveraging EPQT and AI-powered data quality…
In this free webinar, learn how to identify sources of variability in bioassay method transfers…
In this free webinar, learn how medical devices benefit from modern digital validation strategies. Attendees…
Backed by $14M in seed funding led by Andreessen Horowitz, and pre-seed funding led by…